Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 315.00
Bid: 317.00
Ask: 320.00
Change: 3.50 (1.12%)
Spread: 3.00 (0.946%)
Open: 310.00
High: 317.50
Low: 310.00
Prev. Close: 311.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

Tue, 11th Oct 2022 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

Citigroup raises Centrica to 'buy' (neutral) - price target 81 (97) pence

----------

Citigroup raises Compass price target to 2,260 (2,170) pence - 'buy'

----------

Deutsche Bank raises Coca-Cola HBC target to 2,750 (2,700) pence - 'buy'

----------

Bernstein cuts Tesco price target to 250 (330) pence - 'outperform'

----------

Credit Suisse raises Anglo American target to 3,440 (3,290) pence - 'outperform'

----------

Credit Suisse cuts Antofagasta price target to 1,020 (1,040) pence - 'neutral'

----------

Credit Suisse raises Fresnillo price target to 650 (630) pence - 'underperform'

----------

Credit Suisse raises Rio Tinto price target to 5,800 (5,600) pence - 'outperform'

----------

Credit Suisse raises Glencore price target to 760 (720) pence - 'outperform'

----------

Credit Suisse cuts Severn Trent price target to 2,680 (2,800) pence - 'neutral'

----------

JPMorgan raises DS Smith price target to 388 (378) pence - 'overweight'

----------

Credit Suisse cuts Rightmove price target to 490 (608) pence - 'neutral'

----------

JPMorgan cuts Barclays price target to 180 (200) pence - 'neutral'

----------

JPMorgan cuts NatWest price target to 300 (350) pence - 'neutral'

----------

JPMorgan cuts Lloyds Banking price target to 56 (64) pence - 'overweight'

----------

Numis cuts Kingfisher to 'sell' (reduce) - price target 150 (215) pence

----------

Numis raises Next to 'buy' (add) - price target 6,800 (7,000) pence

----------

FTSE 250

----------

HSBC cuts Sirius Real Estate price target to 124 (138) pence - 'buy'

----------

JPMorgan cuts Virgin Money UK price target to 165 (200) pence - 'neutral'

----------

Barclays cuts Moneysupermarket.com target to 220 (230) pence - 'equal weight'

----------

Barclays cuts Future price target to 1,975 (2,500) pence - 'overweight'

----------

Berenberg cuts Marshalls price target to 280 (380) pence - 'hold'

----------

JPMorgan cuts Johnson Matthey price target to 2,150 (2,600) pence - 'neutral'

----------

Goldman Sachs cuts TI Fluid price target to 132 (179) pence - 'neutral'

----------

SMALL CAP

----------

Jefferies reinitiates ITM Power with 'buy' - price target 185 pence

----------

Jefferies reinitiates Ceres Power with 'hold' - price target 365 pence

----------

Citigroup cuts Ceres Power price target to 800 (1500) pence - 'buy'

----------

Barclays cuts Just Eat Takeaway target to 1,490 (1,940) pence - 'equal weight'

----------

RBC raises Oxford BioMedica price target to 1,110 (1,020) pence - 'outperform'

----------

Barclays starts Glenveagh Properties with 'overweight' - price target 1.20 EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more
1 Dec 2020 14:29

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell

Read more
9 Nov 2020 10:01

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development

Read more
9 Nov 2020 09:16

Oxford Biomedica strikes collaboration agreement with PhoreMost

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has inked a discovery collaboration agreement with UK-based biopharmaceutical company PhoreMost.

Read more
4 Nov 2020 09:40

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

UK BROKER RATINGS SUMMARY: BofA Raises Lloyds; Liberum Likes Landsec

Read more
30 Oct 2020 08:47

Oxford Biomedica partner delays Parkinson's disease treatment trial

(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Friday that partner Axovant Gene Therapies had pushed out the start date for its trial into a Parkinson's disease treatment.

Read more
23 Oct 2020 15:15

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

UK DIRECTOR DEALINGS SUMMARY: Liontrust Chiefs Bank GBP1.6 Million

Read more
6 Oct 2020 14:19

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Oxford BioMedica Notes Positive Follow-Up Data From AXO-Lenti-PD

Read more
6 Oct 2020 09:44

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Read more
6 Oct 2020 07:55

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

LONDON BRIEFING: BHP To Increase Stake In Gulf Of Mexico Development

Read more
6 Oct 2020 07:43

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

LONDON MARKET PRE-OPEN: Watches Of Switzerland Ups Full-Year Guidance

Read more
6 Oct 2020 07:03

Oxford Biomedica new manufacturing suite approved

(Sharecast News) - Oxford Biomedica said it had received government approval for a fourth manufacturing suite within its Oxbox facility which will be used to develop a potential Covid-19 vaccine.

Read more
17 Sep 2020 10:43

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Oxford Biomedica Burns Bright Amid AstraZeneca Vaccine Deal

Read more
17 Sep 2020 08:35

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

LONDON MARKET OPEN: Stocks Tumble In US Fed's Wake And Ahead Of BoE

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.